Portfolio Holdings Detail for ISIN IE0031442068

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDUS(USD) LSE
ETF Ticker	IDUS.LS(USD) CXE
ETF Ticker	IUSA.AS(EUR) CXE
ETF Ticker	IUSA.DE(EUR) CXE
ETF Ticker	IUSA.LS(GBX) CXE
ETF Ticker	IUSA.MI(EUR) CXE
ETF Ticker	IUSAz(USD) CXE
ETF Ticker	IUSA(EUR) ETF Plus
ETF Ticker	IDUS.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Core S&P 500 UCITS ETF USD (Dist) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-09-26 (Friday)	885,200	USD 69,541,312	USD 69,541,312
2025-09-25 (Thursday)	885,200	USD 68,691,520	USD 68,691,520	336	USD -1,805,595	USD 77.6	USD 79.67
2025-09-24 (Wednesday)	884,864	USD 70,497,115	USD 70,497,115
2025-09-18 (Thursday)	894,890	USD 72,960,382	USD 72,960,382	340	USD 376,595	USD 81.53	USD 81.14
2025-09-17 (Wednesday)	894,550	USD 72,583,787	USD 72,583,787	340	USD 72,298	USD 81.14	USD 81.09
2025-09-16 (Tuesday)	894,210	USD 72,511,489	USD 72,511,489	0	USD 62,595	USD 81.09	USD 81.02
2025-09-15 (Monday)	894,210	USD 72,448,894	USD 72,448,894
2025-09-12 (Friday)	894,210	USD 74,049,530	USD 74,049,530
2025-09-11 (Thursday)	894,550	USD 76,170,933	USD 76,170,933

Share Trades of MRK by Blackrock for IE0031442068

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-25	BUY	336	79.875	77.600	77.827	GBX 26,150	88.94
2025-09-18	BUY	340			81.530*		88.98
2025-09-17	BUY	340			81.140*		89.02
2025-08-19	SELL	-682			84.930*		89.12 Profit of 60,778 on sale
2025-08-15	SELL	-341	84.740	83.360	83.498	GBX -28,473	89.17 Profit of 1,933 on sale
2025-08-13	SELL	-1,705	82.840	80.200	80.464	GBX -137,191	89.20 Profit of 14,895 on sale
2025-08-12	SELL	-4,433	80.940	79.670	79.797	GBX -353,740	89.25 Profit of 41,889 on sale
2025-08-07	SELL	-5,100	80.820	78.650	78.867	GBX -402,222	89.29 Profit of 53,171 on sale
2025-08-05	BUY	340	81.130	79.570	79.726	GBX 27,107	89.39
2025-07-31	BUY	1,026	81.490	77.850	78.214	GBX 80,248	89.45
2025-07-28	BUY	342	84.970	83.870	83.980	GBX 28,721	89.56
2025-07-25	SELL	-684	85.220	83.840	83.978	GBX -57,441	89.58 Profit of 3,833 on sale
2025-07-24	BUY	342	84.510	83.520	83.619	GBX 28,598	89.61
2025-07-22	SELL	-1,211	81.770	79.870	80.060	GBX -96,953	89.69 Profit of 11,658 on sale
2025-07-18	BUY	343	81.920	79.860	80.066	GBX 27,463	89.80
2025-07-14	SELL	-342	84.300	83.110	83.229	GBX -28,464	89.97 Profit of 2,305 on sale
2025-07-08	SELL	-684	82.380	80.350	80.553	GBX -55,098	90.09 Profit of 6,523 on sale
2025-07-02	BUY	2,052	82.790	81.894	81.983	GBX 168,229	90.30
2025-06-24	SELL	-684	81.460	79.090	79.327	GBX -54,260	90.63 Profit of 7,731 on sale
2025-06-23	SELL	-342	80.220	78.990	79.113	GBX -27,057	90.69 Profit of 3,961 on sale
2025-06-20	SELL	-5,731	79.920	78.600	78.732	GBX -451,213	90.77 Profit of 68,965 on sale
2025-06-12	SELL	-1,029	82.110	80.070	80.274	GBX -82,602	91.05 Profit of 11,085 on sale
2025-06-06	BUY	346	79.490	78.210	78.338	GBX 27,105	91.33
2025-06-02	SELL	-1,029			76.250*		91.71 Profit of 94,367 on sale
2025-05-29	SELL	-343			76.400*		91.91 Profit of 31,526 on sale
2025-05-27	BUY	343	78.200	77.050	77.165	GBX 26,468	92.12
2025-05-23	BUY	343			77.580*		92.32
2025-05-21	SELL	-1,029	78.100	76.870	76.993	GBX -79,226	92.53 Profit of 15,987 on sale
2025-05-16	SELL	-1,239	76.165	74.368	74.547	GBX -92,364	92.86 Profit of 22,692 on sale
2025-05-15	BUY	1,372			74.800*		92.99
2025-05-14	SELL	-2,058			73.470*		93.14 Profit of 191,673 on sale
2025-05-13	SELL	-4,116			76.630*		93.26 Profit of 383,846 on sale
2025-05-07	SELL	-1,029			79.120*		93.71 Profit of 96,428 on sale
2025-05-02	SELL	-343	84.710	82.950	83.126	GBX -28,512	93.99 Profit of 3,726 on sale
2025-04-29	SELL	-1,029	85.690	82.750	83.044	GBX -85,452	94.22 Profit of 11,499 on sale
2025-04-24	BUY	343	79.970	76.030	76.424	GBX 26,213	94.52
2025-04-22	BUY	1,372	79.035	77.660	77.798	GBX 106,738	94.78
2025-04-16	BUY	343	78.690	75.930	76.206	GBX 26,139	95.37
2025-04-15	BUY	343	79.960	77.720	77.944	GBX 26,735	95.51
2025-04-11	BUY	686	79.440	76.360	76.668	GBX 52,594	95.80
2025-04-09	BUY	1,710	81.990	76.000	76.599	GBX 130,984	96.09
2025-04-08	BUY	5,130	83.270	77.540	78.113	GBX 400,720	96.24
2025-04-07	SELL	-2,394	83.210	79.300	79.691	GBX -190,780	96.38 Profit of 39,946 on sale
2025-04-04	SELL	-5,130	86.260	81.090	81.607	GBX -418,644	96.51 Profit of 76,470 on sale
2025-04-02	SELL	-1,026			86.600*		96.61 Profit of 99,117 on sale
2025-04-01	SELL	-342			87.120*		96.69 Profit of 33,069 on sale
2025-03-31	SELL	-684			89.760*		96.76 Profit of 66,183 on sale
2025-03-28	BUY	684			89.230*		96.83
2025-03-25	BUY	1,026			87.870*		97.09
2025-03-24	BUY	1,368			92.310*		97.14
2025-03-21	SELL	-684			93.110*		97.18 Profit of 66,473 on sale
2025-03-20	BUY	684			94.730*		97.21
2025-03-19	BUY	1,368			94.020*		97.24
2025-03-17	SELL	-1,026			94.790*		97.29 Profit of 99,821 on sale
2025-03-14	SELL	-684			94.570*		97.32 Profit of 66,567 on sale
2025-03-13	SELL	-2,052			94.710*		97.35 Profit of 199,758 on sale
2025-03-12	SELL	-1,040			93.350*		97.39 Profit of 101,287 on sale
2025-03-11	SELL	-2,401			94.730*		97.42 Profit of 233,905 on sale
2025-03-10	SELL	-1,372			95.230*		97.44 Profit of 133,693 on sale
2025-03-06	SELL	-1,372			94.000*		97.51 Profit of 133,789 on sale
2025-03-05	SELL	-2,058			93.190*		97.56 Profit of 200,785 on sale
2025-03-04	SELL	-2,744			92.560*		97.62 Profit of 267,871 on sale
2025-02-28	SELL	-1,715	92.350	90.710	90.874	GBX -155,849	97.74 Profit of 11,769 on sale
2025-02-26	BUY	686	91.370	88.860	89.111	GBX 61,130	97.92
2025-02-24	BUY	688	91.850	88.930	89.222	GBX 61,385	98.09
2025-02-21	BUY	343	89.530	87.010	87.262	GBX 29,931	98.19
2025-02-20	SELL	-1,029	87.700	85.900	86.080	GBX -88,576	98.33 Profit of 12,601 on sale
2025-02-14	SELL	-343	84.760	82.094	82.361	GBX -28,250	99.10 Profit of 5,743 on sale
2025-02-13	SELL	-4,459	85.690	84.310	84.448	GBX -376,554	99.30 Profit of 66,240 on sale
2025-02-12	SELL	-343	86.670	85.610	85.716	GBX -29,401	99.49 Profit of 4,724 on sale
2025-02-06	SELL	-1,372	89.571	87.840	88.013	GBX -120,754	100.21 Profit of 16,734 on sale
2025-02-05	BUY	343	90.740	87.995	88.270	GBX 30,276	100.37
2025-02-04	BUY	2,394	91.230	87.330	87.720	GBX 210,002	100.51
2025-01-29	SELL	-2,401	99.150	97.390	97.566	GBX -234,256	100.61 Profit of 7,302 on sale
2025-01-28	BUY	686	98.880	96.590	96.819	GBX 66,418	100.66
2025-01-24	BUY	343	97.100	95.410	95.579	GBX 32,784	100.79
2025-01-22	BUY	684	97.000	95.150	95.335	GBX 65,209	100.95
2025-01-16	BUY	684	100.895	99.950	100.044	GBX 68,430	101.15
2025-01-15	BUY	342	100.820	99.618	99.738	GBX 34,110	101.17
2025-01-10	BUY	684	100.405	98.810	98.969	GBX 67,695	101.25
2025-01-02	BUY	1,026	100.350	98.840	98.991	GBX 101,565	101.35
2024-12-31	BUY	684	99.530	98.434	98.544	GBX 67,404	101.39
2024-12-31	BUY	684	99.530	98.434	98.544	GBX 67,404	101.39
2024-12-27	BUY	342	100.350	99.246	99.356	GBX 33,980	101.50
2024-12-20	SELL	-1,264	99.671	97.900	98.077	GBX -123,969	101.73 Profit of 4,614 on sale
2024-12-19	BUY	343	99.935	97.820	98.031	GBX 33,625	101.78
2024-12-18	SELL	-343	101.500	98.270	98.593	GBX -33,817	101.87 Profit of 1,126 on sale
2024-12-17	BUY	686	100.800	99.360	99.504	GBX 68,260	101.92
2024-12-13	BUY	342	102.570	100.530	100.734	GBX 34,451	101.97
2024-12-11	SELL	-1,754			99.750*		102.04 Profit of 178,978 on sale
2024-12-10	BUY	343	103.770	100.750	101.052	GBX 34,661	102.07
2024-12-06	SELL	-686	103.950	102.690	102.816	GBX -70,532	101.98 Loss of -571 on sale
2024-12-05	BUY	343	104.140	101.350	101.629	GBX 34,859	101.93
2024-12-04	SELL	-2,744	102.090	101.050	101.154	GBX -277,567	101.95 Profit of 2,185 on sale
2024-12-03	BUY	1,029	102.450	100.620	100.803	GBX 103,726	101.95
2024-12-02	BUY	1,715	101.850	100.460	100.599	GBX 172,527	102.00
2024-11-27	BUY	343	103.450	101.640	101.821	GBX 34,925	101.93
2024-11-26	BUY	2,401	101.800	99.700	99.910	GBX 239,884	101.94
2024-11-21	BUY	1,032	100.480	96.950	97.303	GBX 100,417	102.22
2024-11-20	BUY	686	98.840	96.660	96.878	GBX 66,458	102.47
2024-11-19	BUY	343	97.550	95.260	95.489	GBX 32,753	102.80
2024-11-18	BUY	686	97.290	95.420	95.607	GBX 65,586	103.17
2024-11-12	BUY	1,372	100.760	98.500	98.726	GBX 135,452	103.46
2024-11-11	BUY	686	103.370	100.460	100.751	GBX 69,115	103.64
2024-11-08	BUY	2,744	103.230	101.020	101.241	GBX 277,805	103.69
2024-11-07	BUY	2,401	101.690	100.850	100.934	GBX 242,343	103.88
2024-11-06	BUY	2,744	103.230	100.605	100.868	GBX 276,780	104.14
2024-11-05	SELL	-686	101.730	100.520	100.641	GBX -69,040	104.37 Profit of 2,559 on sale
2024-11-04	BUY	686	102.530	100.950	101.108	GBX 69,360	104.62
2024-11-01	BUY	2,401	102.720	101.210	101.361	GBX 243,368	104.93
2024-10-28	BUY	1,715	105.000	103.930	104.037	GBX 178,423	105.84
2024-10-25	BUY	3,773	106.490	103.860	104.123	GBX 392,856	106.31
2024-10-23	SELL	-343	107.360	106.200	106.316	GBX -36,466	106.49 Profit of 60 on sale
2024-10-21	BUY	343	109.170	106.180	106.479	GBX 36,522	0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer